Evidence map›Paper›PMID 41583564›Full record

ArticleiScience2026

Dimensionality-modulated generative AI for safe biomedical dataset augmentation.

Jörn Lötsch, André Himmelspach, Dario Kringel

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jörn LötschGoethe University, Institute of Clinical Pharmacology, Faculty of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
André HimmelspachGoethe University, Institute of Clinical Pharmacology, Faculty of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Dario KringelGoethe University, Institute of Clinical Pharmacology, Faculty of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generative AI can expand small biomedical datasets but may amplify noise and distort statistical relationships. We developed genESOM, a framework integrating an error control system into a generative AI method based on emergent self-organizing maps. By separating structure learning from data synthesis, genESOM enables dimensionality modulation and injection of engineered diagnostic features, i.e., permuted versions of real variables, as negative controls that track feature importance stability. A data-driven stopping criterion halts augmentation when error inflation begins, limiting overfitting. Validation across two artificial and six biomedical datasets, including preclinical and clinical domains, showed that moderate augmentation (one synthetic sample per original) preserved variable ranking and yielded strong negative correlations (Kendall's tau: -0.53 to -0.85) between statistical significance and feature selection frequency. Excessive augmentation disrupted these relationships. Moderate preclinical augmentation safely doubled sample sizes without compromising analytical reliability and supported up to 50% reductions in laboratory animal use.

Indexed as

Artificial intelligenceHealth informatics

Identifiers

PMID41583564
PMCPMC12828417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.